메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 22, Issue 17, 2004, Pages 3646-
Testing for epidermal growth factor receptor in lung cancer: Have we learned anything from HER-2 testing?
Author keywords

[No Author keywords available]
Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;
EID: 4444293489     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2004.99.015     Document Type: Letter
Times cited : (10)
References (6)
  • 1
    • 0142119289 scopus 로고    scopus 로고
    • Epidermal growth factor receptor in non-small-cell lung carcinomas: Correlation between gene copy number and protein expression and impact on prognosis
    • Hirsch FR, Varella-Garcia M, Bunn PA Jr, et al: Epidermal growth factor receptor in non-small-cell lung carcinomas: Correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 21: 3798-3807, 2003
    • (2003) J Clin Oncol , vol.21 , pp. 3798-3807
    • Hirsch, F.R.1    Varella-Garcia, M.2    Bunn, P.A.3
  • 2
    • 0035447953 scopus 로고    scopus 로고
    • Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: Implications for a standardized scoring system
    • Goldstein NS, Armin M: Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: Implications for a standardized scoring system. Cancer 92: 1331-1346, 2001
    • (2001) Cancer , vol.92 , pp. 1331-1346
    • Goldstein, N.S.1    Armin, M.2
  • 3
    • 0032928459 scopus 로고    scopus 로고
    • Amplification and overexpression of the cyclin D1 and epidermal growth factor receptor genes in non-small-cell lung cancer. Lung Cancer Study Group
    • Reissmann PT, Koga H, Figlin RA, et al: Amplification and overexpression of the cyclin D1 and epidermal growth factor receptor genes in non-small-cell lung cancer. Lung Cancer Study Group. J Cancer Res Clin Oncol 125: 61-70, 1999
    • (1999) J Cancer Res Clin Oncol , vol.125 , pp. 61-70
    • Reissmann, P.T.1    Koga, H.2    Figlin, R.A.3
  • 4
    • 0029144781 scopus 로고
    • Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinomas of the urinary bladder: A study in Greek patients
    • Gorgoulis VG, Barbatis C, Poulias I, et al: Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinomas of the urinary bladder: A study in Greek patients. Mod Pathol 8: 758-764, 1995
    • (1995) Mod Pathol , vol.8 , pp. 758-764
    • Gorgoulis, V.G.1    Barbatis, C.2    Poulias, I.3
  • 5
    • 0034327895 scopus 로고    scopus 로고
    • Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: A direct comparison of fluorescence in situ hybridization and immunohistochemistry
    • Pauletti G, Dandekar S, Rong H, et al: Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: A direct comparison of fluorescence in situ hybridization and immunohistochemistry. J Clin Oncol 18: 3651-3664, 2000
    • (2000) J Clin Oncol , vol.18 , pp. 3651-3664
    • Pauletti, G.1    Dandekar, S.2    Rong, H.3
  • 6
    • 0036836117 scopus 로고    scopus 로고
    • Testing for HER-2/neu in breast cancer: Is fluorescence in situ hybridization superior in predicting outcome?
    • Yaziji H, Gown AM: Testing for HER-2/neu in breast cancer: Is fluorescence in situ hybridization superior in predicting outcome? Adv Anat Pathol 9: 338-344, 2002
    • (2002) Adv Anat Pathol , vol.9 , pp. 338-344
    • Yaziji, H.1    Gown, A.M.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.